Develops vaccines for infectious diseases and cancer.
Jun 2026Revenue $2.23B/yrExpenses $5.55B/yr
No trendCash runway ≈ 4.1 years from Jun 2026
Figures by year
When will Moderna be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $2.23B and expenses $5.55B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $1.94B | $5.02B | −$3.07B |
| Dec 2024 | $3.24B | $7.18B | −$3.94B |
| Dec 2023 | $6.85B | $11.1B | −$4.24B |
| Dec 2022 | $19.3B | $9.84B | $9.42B |
| Dec 2021 | $18.5B | $5.17B | $13.3B |
| Dec 2020 | $803M | $1.57B | −$763M |
| Dec 2019 | $60.2M | $606M | −$546M |
| Dec 2018 | $135M | $548M | −$413M |
| Dec 2017 | $206M | $475M | −$269M |
| Dec 2016 | $108M | $332M | −$224M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.